期刊文献+

心理护理对慢性精神分裂症患者认知功能的影响 被引量:5

Effect of mental mursing in the treatment of Schizophrenia on cognition function
下载PDF
导出
摘要 目的观察心理护理对慢性精神分裂症患者认知功能的影响。方法采用入院顺序分层随机法,将120例慢性精神分裂症患者平均分为研究组(心理护理+奋乃静)和对照组(单用奋乃静)治疗。在治疗前,治疗后4、8、12周末分别以阳性症状和阴性症状量表(PNASS)评定疗效,用韦氏成人智力量表(WAIS-R)、韦氏记忆量表(WMS)评定治疗前后患者认知功能的改变。结果治疗12周后,研究组的言语量表、操作量表、全量表和记忆量表分分别为84.97±3.73、80.41±5.93、83.37±5.81、77.26±13.31;对照组分别为75.41±3.95、72.43±5.56、75.87±5.34、72.15±13.19,两组有显著差异(P<0.01)。PANSS总分、阴性因子分比治疗前明显降低。结论心理护理治疗对精神分裂症患者认知功能有明显改善。 Objective To observe the cognition function of mental muming in the treatment of schizo- phrenia. Methods Being used the vendom control stady,60 in-patients with chyonic schizophreaia were divided into study gooup( Mental mursing and perphenazine)and control group (perphenazine). Effects and side effects were assessed with PANSS respectively WAIS-R, WMS were evaluated before treatment and after 4. 8.12 weeks treatment. Results After treating 12 turnovers, study the speech quantity form of the set and operate to measure the form,the whole quantity form and memories to measure the watch to distinguish for84.97± 3.73,80. 41± 5.93,83. 37 ± 5.81,77. 26 ± 13. 31 ;The matched control distinguishes for75.41 ± 3.95,72. 43± 5.56,75. 87 ± 5.34,72. 15 ±13. 19, two the sets show the difference of high( P 〈 0. 01 ). the todal scores of PANSS and the scores of negative factor were signficantly decreased. Conclusion It suggests that mental mursing, could improvve distinctly the cognition function of schizophrenia patients.
出处 《中国实用医药》 2009年第22期190-192,共3页 China Practical Medicine
关键词 精神分裂症 认知功能 心理护理 Schizophrenia Cognition function Mental nursing
  • 相关文献

参考文献4

二级参考文献26

  • 1修订韦氏成人智力量表全国协作组.韦氏成人智力量表的修订[J].心理学报,1983,15(3):362-370. 被引量:57
  • 2方永璋.慢性精神分裂症的智力测验[J].中国神经精神疾病杂志,1984,10(2):82-82.
  • 3Marcella AJ. Stree,social supports,and schizophrenia disordor. Schizophrenia Bulletin 1981:7:152
  • 4Mackay AVP. Positive and negative schizophrenia symptoms and the role of dopamine. Br J Pychiatry 1980;137:397
  • 5Libtrman RP. Social skills training for psychiatric patients. New York:Pergarmon Press 1989:10-2,26-196
  • 6Kay Sk. Interpretation of the positive-negative distinction//Kay SE. Positive and negative syndrome in schizophrenia:assessment and research New York:Brunner/Muzel 1991:194-210
  • 7Cancro R Schizophrenia:Clinical features//Sadock BJ.Compre-hensive Textbook of Psychiatry/Ⅶ.Baltimore:Williams & Wilkins 2000:1198-9
  • 8Elliott R. Executive functions and their disorders.Imaging neuroscience: Clinical frontiers for diagnosis and management.Br Med Bull,2003,65:49-59.
  • 9Carlsson A, Hansson LO. A glutaergic deficiency model of schizophrenia. Br J Psychiatry, 1999,174(Suppl 37):2.
  • 10Wassef A,Baker J, Kochan LD. GABA and Schizophrenia: A review of basic science and clinical studies. J Clin Psychopharmacology, 2003,23(6):601-640.

共引文献91

同被引文献41

引证文献5

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部